Aspen Pharmacare - Generic Company Intelligence Report

SUMMARY

Aspen Pharmacare is Africa's largest manufacturer of generic drugs, and the leading supplier of generic products to both the private and public sectors in South Africa. Aspen has pioneered the development of generic drugs in South Africa. This report provides an insight into the company, reviewing its current business structure and activities.

Aspen Pharmacare's present form started with the company's listing on the Johannesburg Stock Exchange through the reverse takeover of Medhold in July 1998. In January 1999, Medhold was renamed Aspen, and in March 1999, Aspen acquired the pharmaceutical business of South African Druggists, Pharmacare Limited. One of Pharmacare's leading brands is Lennon, which comprised Pharmacare's generic drugs portfolio, and has a well-established position in the South African market. The company renamed itself Aspen Pharmacare in May 2000. Aspen claims to be the largest pharmaceutical firm listed on the Johannesburg Stock Exchange, and aims to be the largest and most dynamic pharmaceutical business in South Africa.

The company is split into two divisions, the Pharmaceutical Division and the Consumer Division; each of these are then further sub-divided into business areas. The Pharmaceutical Division comprises the company's Generics business and its Ethicals business. Aspen claims to be the largest supplier of generic pharmaceuticals to both the private and public sectors in South Africa. Aspen's generic drugs range is the core of its public sector business, including the supply of state tenders, public sector hospitals and parastatal institutions.

Aspen's Ethicals business markets a wide range of original drugs, and the company claims to be a leader in the female healthcare, tranquillisers and hypnotics, and cardiovascular medicines categories.

The Consumer Division is split into Aspen's OTC business and Fast Moving Consumer Goods business. The company's OTC goods are distributed solely to pharmacies; the company has a niche in the natural product sector and in lifestyle products, such as slimming products. The FMCG business is distributed through retail chains, and includes products such as deodorants.

In addition to the company's presence in South Africa, Aspen also has a presence in foreign markets. The company has 337 dossiers registered abroad, and exports to over 30 countries. Most of these are in Sub-Saharan and North Africa, but other markets are in Asia Pacific, Central America, the Middle East and North America.

Aspen also has businesses in Australia and the United Kingdom.

In addition, Aspen set up another UK-based subsidiary, Aspen Resources, in 2004. The subsidiary has been set up to acquire intellectual property in international markets. It will also procure the related products and supply these to subcontracted distributors. Aspen Resources' first acquisition was of twelve products in the Australian market from Eli Lilly.

This report provides information on the company's active product lines and ANDA approvals, along with a review of major developments, such as M&A activity, strategic alliances and litigation. The company's most recent quarterly and annual financial results are illustrated with comparative figures, charts and a detailed review of the data which allows you to track the company's progress.

TABLE OF CONTENTS

• EXECUTIVE SUMMARY
• INTRODUCTION
• PRODUCTS
  • HIV/AIDS drugs
  • Recent product approvals
  • Efavirenz
  • South African government ARV tender
  • PEPFAR
  • Antiretrovirals
  • Citalopram
• FINANCIAL RESULTS
  • Latest Yearly Results
    • Latest Full Year Results
    • Segment Data
    • Segment Results -- Full Year
    • International Revenues by Geographic Region
  • Latest Quarterly Results, six months ended 31st December 2005
    • Half Year Results
• MAJOR DEVELOPMENTS
  • Mergers, acquisitions and agreements
    • Bristol-Myers Squibb
    • Lupin Laboratories
    • Gilead
    • Matrix Laboratories
    • Fine Chemicals Corporation
    • William J Clinton Presidential Foundati
    • Eli Lilly
    • GlaxoSmithKline
    • Strides Arcolab
• CONTACT DETAILS